Skip to main content
CCL Products (India) Ltd. logo

CCL Products (India) Ltd. — Investor Relations & Filings

Ticker · CCL ISIN · INE421D01022 LEI · 3358004YMWO3ILPLLM24 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2025-05-05 Capital/Financing Update
Country IN India
Listing BSE.NS CCL

About CCL Products (India) Ltd.

https://www.cclproducts.com

CCL Products (India) Ltd. is a global manufacturer and exporter specializing in instant coffee production. The company provides a comprehensive range of products, including spray-dried coffee powder, freeze-dried coffee, coffee granules, and roasted coffee beans. It operates advanced processing facilities to supply customized coffee solutions to private labels, major retailers, and institutional clients across more than 90 international markets. The product portfolio encompasses pure coffee and chicory-blended varieties, designed to meet specific quality standards. By utilizing large-scale production capacities and sophisticated processing technologies, the organization maintains a significant role in the global supply chain, focusing on product consistency and technical excellence for diverse market requirements.

Recent filings

Filing Released Lang Actions
We wish to inform you that the 1) expansion of M/s. Ngon Coffee Company Limited has been completed. 2)the board has approved the availing of group captive mode of hybrid power purchase ....
Capital/Financing Update Classification · 95% confidence The document is a short communication addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the completion of an expansion at a subsidiary and approval of a power purchase investment by the Board of Directors. The document is brief (1529 characters) and serves as an update or announcement rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under Capital/Financing Update (CAP) as it relates to investment approval and operational expansion, which are capital-related activities disclosed to the market as per regulatory requirements.
2025-05-05 English
Grant of 6000 options under CCL Employee Stock Option Scheme 2022
Capital/Financing Update Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the grant of stock options under an employee stock option scheme. It references compliance with SEBI regulations and provides detailed information about the stock options granted, including number of options, exercise price, vesting criteria, and other terms. The document is an announcement of a capital-related event (grant of stock options) rather than a financial report or management discussion. It does not contain financial statements or earnings data. The document length is under 5,000 characters and is a formal notification to the exchanges. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock option grants.
2025-05-05 English
The results for the quarter and year ended March 31, 2025 is attached herewith.
Regulatory Filings
2025-05-05 English
We wish to inform you that the Board has recommended a dividend of Rs. 5.00 per equity share (250%) for the financial year ended March 31, 2025.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges reporting the outcome of a Board Meeting. It includes approval of audited financial results for the fiscal year ended March 31, 2025, recommendation of a final dividend, and other corporate decisions. The document is short (1999 characters) and serves as an announcement of decisions made at the Board Meeting rather than the full financial report itself. It does not contain detailed financial statements or analysis, but rather summarizes key outcomes. Therefore, it fits best as a Regulatory Filing (RNS) since it is a formal announcement to the exchanges about board decisions and financial results approval, not the full Annual Report or Earnings Release.
2025-05-05 English
The financial results for the fourth quarter and year ended March 31, 2025 is attached herewith
Regulatory Filings
2025-05-05 English
Outcome of Board Meeting
Regulatory Filings
2025-05-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.